Clinical Trial: A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and the Safety of UIC202502 and UIC202505 in Healthy Adult Volunteers

U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07162441) titled 'A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and the Safety of UIC202502 and UIC202505 in Healthy Adult Volunteers' on Aug. 31.

Brief Summary: This study is open-label, multiple-dose, two-intervention group, single-sequence, crossover design to compare the safety and pharmacokinetics of UIC202502 and UIC202505 when administered alone or in combination.

Study Start Date: Aug. 12

Study Type: INTERVENTIONAL

Condition: Dyslipidemia

Intervention: DRUG: treatment A

UIC202502 1 Tab/day for 7 days

DRUG: treatment B

UIC202505 1 Tab/day for 7 days

DRUG: treatmen...